The third International Stroke Trial (IST-3)
Date Available
2021-01-25Type
datasetData Creator
Sandercock, PWardlaw, Joanna
Lindley, R
Cohen, G
Whiteley, W
Publisher
University of Edinburgh & Edinburgh Clinical Trials UnitRelation (Is Referenced By)
https://doi.org/10.1016/S0140-6736(16)30414-7Metadata
Show full item recordAltmetric
Citation
Sandercock, P; Wardlaw, J; Lindley, R; Cohen, G; Whiteley, W. (2016). The third International Stroke Trial (IST-3), 2000-2015 [dataset]. University of Edinburgh & Edinburgh Clinical Trials Unit. https://doi.org/10.7488/ds/1350Description
The IST-3 trial is a large-scale randomised controlled trial of intravenous thrombolytic therapy of the drug Alteplase for patients with acute ischaemic stroke. The dataset includes a number of files describing the IST-3 dataset. The documentation files may be freely downloaded. The patient-level data are under embargo until the 25th of January 2021. To apply to the study investigators for access to the raw patient-level data before that time, please click on the file (“datashare_aug2015.sas7bdat” or “ist3.dat”) and follow the instructions. Further information about the study is available at www.ist3.com. *** The IST3 has an international trials registry ID number, which enables all the trials outputs to be linked: ISRCTN25765518 https://doi.org/10.1186/ISRCTN25765518The following licence files are associated with this item: